107 related articles for article (PubMed ID: 12466347)
1. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness.
Mesotten D; Delhanty PJ; Vanderhoydonc F; Hardman KV; Weekers F; Baxter RC; Van Den Berghe G
J Clin Endocrinol Metab; 2002 Dec; 87(12):5516-23. PubMed ID: 12466347
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness.
Mesotten D; Wouters PJ; Peeters RP; Hardman KV; Holly JM; Baxter RC; Van den Berghe G
J Clin Endocrinol Metab; 2004 Jul; 89(7):3105-13. PubMed ID: 15240578
[TBL] [Abstract][Full Text] [Related]
3. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy.
Mesotten D; Swinnen JV; Vanderhoydonc F; Wouters PJ; Van den Berghe G
J Clin Endocrinol Metab; 2004 Jan; 89(1):219-26. PubMed ID: 14715853
[TBL] [Abstract][Full Text] [Related]
4. Effect of intensive insulin therapy on the somatotropic axis of critically ill children.
Gielen M; Mesotten D; Brugts M; Coopmans W; Van Herck E; Vanhorebeek I; Baxter R; Lamberts S; Janssen JA; Van den Berghe G
J Clin Endocrinol Metab; 2011 Aug; 96(8):2558-66. PubMed ID: 21632816
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance in critically ill patients with acute renal failure.
Basi S; Pupim LB; Simmons EM; Sezer MT; Shyr Y; Freedman S; Chertow GM; Mehta RL; Paganini E; Himmelfarb J; Ikizler TA
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F259-64. PubMed ID: 15840772
[TBL] [Abstract][Full Text] [Related]
6. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia.
Tönshoff B; Powell DR; Zhao D; Durham SK; Coleman ME; Domené HM; Blum WF; Baxter RC; Moore LC; Kaskel FJ
Endocrinology; 1997 Mar; 138(3):938-46. PubMed ID: 9048593
[TBL] [Abstract][Full Text] [Related]
7. Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors.
de Groof F; Joosten KF; Janssen JA; de Kleijn ED; Hazelzet JA; Hop WC; Uitterlinden P; van Doorn J; Hokken-Koelega AC
J Clin Endocrinol Metab; 2002 Jul; 87(7):3118-24. PubMed ID: 12107211
[TBL] [Abstract][Full Text] [Related]
8. Effect of intensive insulin therapy on insulin sensitivity in the critically ill.
Langouche L; Vander Perre S; Wouters PJ; D'Hoore A; Hansen TK; Van den Berghe G
J Clin Endocrinol Metab; 2007 Oct; 92(10):3890-7. PubMed ID: 17666481
[TBL] [Abstract][Full Text] [Related]
9. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
Benbassat CA; Maki KC; Unterman TG
J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 alpha (IL-1 alpha) and tumor necrosis factor alpha (TNF alpha) regulate insulin-like growth factor binding protein-1 (IGFBP-1) levels and mRNA abundance in vivo and in vitro.
Benbassat CA; Lazarus DD; Cichy SB; Evans TM; Moldawer LL; Lowry SF; Unterman TG
Horm Metab Res; 1999; 31(2-3):209-15. PubMed ID: 10226804
[TBL] [Abstract][Full Text] [Related]
12. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
[TBL] [Abstract][Full Text] [Related]
13. FGF21 Response to Critical Illness: Effect of Blood Glucose Control and Relation With Cellular Stress and Survival.
Thiessen SE; Vanhorebeek I; Derese I; Gunst J; Van den Berghe G
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1319-27. PubMed ID: 26274346
[TBL] [Abstract][Full Text] [Related]
14. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
Olivecrona H; Hilding A; Ekström C; Barle H; Nyberg B; Möller C; Delhanty PJ; Baxter RC; Angelin B; Ekström TJ; Tally M
J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415
[TBL] [Abstract][Full Text] [Related]
15. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
[TBL] [Abstract][Full Text] [Related]
16. Expression of insulin-like growth factor-I and insulin-like growth factor binding proteins during thioacetamide-induced liver cirrhosis in rats.
Novosyadlyy R; Dargel R; Scharf JG
Growth Horm IGF Res; 2005 Oct; 15(5):313-23. PubMed ID: 16098781
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R
Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
19. Effects of fasting on IGF-I, IGF-II, and IGF-binding protein mRNA concentrations in channel catfish (Ictalurus punctatus).
Peterson BC; Waldbieser GC
Domest Anim Endocrinol; 2009 Aug; 37(2):74-83. PubMed ID: 19446983
[TBL] [Abstract][Full Text] [Related]
20. Increased thyroxine sulfate levels in critically ill patients as a result of a decreased hepatic type I deiodinase activity.
Peeters RP; Kester MH; Wouters PJ; Kaptein E; van Toor H; Visser TJ; Van den Berghe G
J Clin Endocrinol Metab; 2005 Dec; 90(12):6460-5. PubMed ID: 16189257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
